Belatacept in Kidney Transplant Recipients With Failed Allografts for the Prevention of Humoral Sensitization: A Pilot Randomized Controlled Trial

Transplantation. 2021 Dec 1;105(12):e395-e396. doi: 10.1097/TP.0000000000003852.

Affiliations

¹ Emory Transplant Center, Emory University, Atlanta, GA.
² Department of Pathology, Emory University, Atlanta, GA.
³ Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA.

PMID: 34818307
DOI: 10.1097/TP.0000000000003852

No abstract available

Publication types

Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Abatacept / therapeutic use
Allografts
Graft Rejection / prevention & control
Graft Survival
Humans
Immunosuppressive Agents / therapeutic use
Kidney Transplantation* / adverse effects
Pilot Projects
Transplant Recipients

Substances

Immunosuppressive Agents
Abatacept